HTR1A and major depressive disorder: Buspirone and other 5-HT1A receptor partial agonists and antagonists are also reported to enhance the therapeutic effects of antidepressants (Blier and Ward, 2003), as seen in the Sequenced Treatment Alternatives to Relieve Depression (STAR∗D) study (Trivedi et al., 2006a) (Figure 1).